EUVIMEDEUVIMED entdecken
Leserbrief

Necrotizing Fasciitis Caused by Achromobacter xylosoxidans in an Immunocompromised Patient With Chronic Venous Ulcers

Ayano Maruyama iD, Kenji Shimizu, Shinya Imamura, Yukimasa Tai, Takeshi Fukumoto iD

The Journal of Dermatology · 2026-06 · 53 (6)

DOI: 10.1111/1346-8138.70259 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 06.04.2026. Verfasst von Ayano Maruyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Achromobacter xylosoxidansnecrotizing fasciitisperipheral T‐cell lymphomavalemetostat

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

ORCID-Profile: Ayano Maruyama, Takeshi Fukumoto

Zitieren

APA

Maruyama, A., Shimizu, K., Imamura, S., Tai, Y., & Fukumoto, T. (2026). Necrotizing Fasciitis Caused by Achromobacter xylosoxidans in an Immunocompromised Patient With Chronic Venous Ulcers. The Journal of Dermatology, 53(6). https://doi.org/10.1111/1346-8138.70259

Vancouver

Maruyama A, Shimizu K, Imamura S, Tai Y, Fukumoto T. Necrotizing Fasciitis Caused by Achromobacter xylosoxidans in an Immunocompromised Patient With Chronic Venous Ulcers. The Journal of Dermatology. 2026;53(6). doi:10.1111/1346-8138.70259

BibTeX
@article{Maruyama2026,
  author = {Maruyama, Ayano and Shimizu, Kenji and Imamura, Shinya and Tai, Yukimasa and Fukumoto, Takeshi},
  title = {Necrotizing Fasciitis Caused by Achromobacter xylosoxidans in an Immunocompromised Patient With Chronic Venous Ulcers},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {6},
  doi = {10.1111/1346-8138.70259}
}
Kostenlos starten →